3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Breast Neoplasms
3
Polycystic Ovary Syndrome
2
Obesity
2
Neoplasms
2
Motor Activity
2
Feeding Behavior
2
Cardiovascular Diseases
2
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Overweight
1
Neuroendocrine Tumors
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Multiple Endocrine Neoplasia Type 1
1
Metabolic Syndrome
1
Intermittent Fasting
1
Inflammation
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Diabetes Mellitus
1
Cognitive Dysfunction
1
Angina, Unstable
1
Interventions
Everolimus
17
lutetium Lu 177 dotatate
7
Octreotide
7
pasireotide
6
lanreotide
6
gallium Ga 68 dotatate
5
Temozolomide
5
Sunitinib
5
Positron Emission Tomography Computed Tomography
5
surufatinib
4
pembrolizumab
4
Sorafenib
4
Data Collection
4
Carboplatin
4
3-Iodobenzylguanidine
4
Positron-Emission Tomography
3
Nivolumab
3
Etoposide
3
Capecitabine
3
90Y-octreotide, DOTA-Tyr(3)-
3
pentetreotide
2
pazopanib
2
lenvatinib
2
fosbretabulin
2
fluorodopa F 18
2
cabozantinib
2
avelumab
2
arginyllysine
2
Single Photon Emission Computed Tomography Computed Tomography
2
Pemetrexed
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neuroendocrine Tumors
×
Diet, Mediterranean
×
Clear all
NCT03592940
2018-07-19
NetNutr
Federico II University
Completed
100 enrolled